Atria Investments LLC Neurocrine Biosciences Inc Transaction History
Atria Investments LLC
- $7.33 Billion
- Q1 2025
A detailed history of Atria Investments LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Atria Investments LLC holds 9,259 shares of NBIX stock, worth $1.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,259
Previous 5,095
81.73%
Holding current value
$1.11 Million
Previous $695,000
47.34%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
97.2MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.19 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$665 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$584 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$321 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...